Mutations before IM
No MMR n (%)
MMR n (%)
p
OR
Yes
8 (34.7%)
1 (4.7%)
10.7
No
15 (65.3%)
20 (95.3%)
0,01
1
Total
23 (100%)
21 (100%)
Table 6:
Relationship between BCR-Abl gene mutation with MMR at CML patients.
